In-person conference with key opinion leaders to discuss options such as cannabinoid therapy in an effort to help manage addictions to various substances including opiates, alcohol and tobacco.
Interactive Zoom lecture for the Parkinson's Society of Southern Ontario. Discussion of various aspects to be considered when determining whether medical cannabis would be a suitable option in the management of Parkinson’s Disease (PD) symptoms. This presentation will include the history of cannabis for therapeutic purposes including a review of the science, description of cannabinoids, […]
A Microsoft Teams webinar with cannabinoid clinic educators outlining the potential applications of medical cannabis through the exploration of the endocannabinoid system (ECS). It will also discuss the implications of alterations in the ECS and how supplementing with phytocannabinoids may be beneficial for ameliorating symptoms. The latest research into ‘minor’ cannabinoids such as CBN will […]
A combination live streaming webinar followed by an in-person meeting to discuss the potential role that medical cannabis may play in reducing the overall pill burden for many patients. Polypharmacy can lead to multiple side effects along with serious drug interactions that are responsible for significant morbidity and hospitalizations. This interactive discussion will address the […]
Back by popular demand-an encore presentation of ‘Dosed 2: The Trip of a Lifetime’ featuring a cameo role in the movie followed by moderating a panel discussion on cannabinoid along with psychedelic therapy. This documentary revolves around the story of a patient using psychedelics to assist in her final transition while saying goodbye to friends […]
A Microsoft Teams webinar with cannabinoid clinic educators outlining the potential applications of medical cannabis through the exploration of the endocannabinoid system (ECS). It will also discuss the implications of alterations in the ECS and how supplementing with phytocannabinoids may be beneficial for ameliorating symptoms. The latest research into ‘minor’ cannabinoids such as CBN will […]